Dr. Aditya Murali

• MBBS: Kasturba Medical College, Mangalore (2007).
• MD (General Medicine): Madurai Medical College, Madurai (2013).
• DM (Medical Oncology): Cancer Institute (WIA), Adyar, Chennai (2016).

• Observership in BMT & Cellular Therapy: Memorial Sloan Kettering Cancer Center, New York, USA (2018).
• ECFMG Certification: Education Commission for Foreign Medical Graduates, USA (2009).

• ECMO: European Society of Medical Oncology Certification (2016).
• DNB (Medical Oncology): Diplomate of National Board (2017).
• MRCP – SCE (Medical Oncology): Royal College of Physicians, UK.
• Training: Adyar Cancer Institute, Chennai

• Acute Myeloid Leukaemia (AML)
• Acute Lymphoblastic Leukaemia (ALL)
• Multiple Myeloma & Lymphomas
• Lung Cancer (Small Cell & Non-Small Cell)
• Breast Cancer
• Ovarian Cancer
• Gastrointestinal Cancers (Colon, Stomach, Rectum)
• Head & Neck Cancers

• Haemato-Oncology
• Bone Marrow Transplantation (Allogeneic & Autologous)
• Immuno-Oncology
• Bone Sarcomas

• Bone Marrow Transplantation (BMT): For Leukaemia, Myeloma, and other blood disorders.
• Immunotherapy: Using checkpoint inhibitors for Lung and Bladder cancers.
• Targeted Therapy: Precision treatment for mutations like EGFR, ALK in lung cancer.
• Cellular Therapy: Advanced management for relapsed blood cancers.

• Senior Consultant – Medical Oncology, Apollo Hospitals, Bannerghatta Road, Bangalore.

• Consultant – Medical Oncology & BMT, Sarvodaya Hospital, Faridabad (2016 - 2018).
• Consultant, Moolchand Medicity and Holy Family Hospital, New Delhi.

• Part of the team that performed the first Haploidentical Bone Marrow Transplant in Faridabad.
• Successfully treated over 5,000 cancer cases in his career.
• Conducted significant research on multi-drug resistant septicaemia in AML patients during his tenure at Adyar Cancer Institute.

• National Finalist at TYSA 2016 (The Young Super Achievers) - Best Young Oncologist.
• Second Prize in Haematology Quiz at HEMATOCON 2015.

Memberships

• Member of the European Society for Medical Oncology (ESMO).
• Member of the Royal College of Physicians (MRCP-SCE).

Published Papers in Medical Journals:

• Outcomes in Lung Cancer: 9-Year Experience From a Tertiary Cancer Center in India – Journal of Global Oncology (2017).
• Increasing incidence of multi-drug resistant Gram-negative septicemia during induction therapy of acute myeloid leukemia – Journal of Hospital Infection (2016).
• Inadvertent intramuscular administration of vincristine in two pediatric patients with uneventful outcomes – Indian Journal of Cancer (2016).

Ongoing Clinical Trials Participation:
Dr. Murali participates in trials related to new Immunotherapy drugs for solid tumours and novel conditioning regimens for Bone Marrow Transplants, ensuring his patients have access to the latest treatments.

Notable Cases Handled:

• Successfully performed a Haploidentical Bone Marrow Transplant for a young patient with high-risk Acute Myeloid Leukaemia who lacked a fully matched donor.
• Managed a Stage IV Lung Cancer patient with brain metastases using targeted therapy, achieving disease control for over 4 years.
• Treated a complex case of Hairy Cell Leukaemia, achieving complete remission with minimal toxicity.

Patients Feedback

• Highly Trusted Medical Oncologist and Bone Marrow Transplant Expert
  Patients consistently highlight strong expertise in bone marrow transplantation, blood cancer treatment, and advanced medical oncology care. Feedback reflects confidence in handling complex leukaemia, lymphoma, and myeloma cases with structured, outcome-driven treatment plans.
• Clear Communication and Reassuring Patient-Centric Care
  Widely appreciated for explaining cancer diagnosis, chemotherapy, immunotherapy, and transplant protocols in clear, simple language. Patients value the time spent on counselling, emotional reassurance, and informed decision-making throughout the cancer journey.
• Advanced Precision Oncology with Modern Therapies
  Recognised for effective use of immunotherapy, targeted therapy, and genetic testing in lung cancer and other solid tumours. Patients report improved treatment tolerance, personalised care, and better quality of life through evidence-based precision oncology.

• Patient-Centred Care:
  Dr. Murali's philosophy is rooted in empathy and education. He believes that an informed patient is an empowered patient. He spends time discussing the diagnosis, treatment options, and potential side effects, ensuring that the treatment plan aligns with the patient's personal goals and lifestyle.
• Technology & Innovation:
  Trained at MSKCC, New York, Dr. Murali brings global standards to his practice in India. He is a strong proponent of using Next-Generation Sequencing (NGS) to find targeted solutions for cancer, minimising the "trial and error" approach of traditional chemotherapy.

The table below provides estimated costs for oncology treatments and procedures managed by Dr. N. Aditya Murali. 

Note: For appointment booking and to get a personalised cost estimate, you can connect with the Cancer Rounds team.

Language Support:
The Cancer Rounds team provides dedicated language interpretation to ensure clear communication for international patients consulting with Dr. N. Aditya Murali.

Visa & Travel Assistance:
We assist with medical visa invitations, airport transfers, and arranging accommodation near Apollo Hospitals, Bannerghatta Road, for long-term treatments like BMT.

Pre-treatment Virtual Consultations:
International patients can book a video consultation with Dr. Murali via Cancer Rounds to discuss their diagnosis and feasibility of travel for treatment.